WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , IFSIJ Measure of Journal Quality , Scientific Journal Impact Factor (SJIF) , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , 

ISSN 2457-0400

Impact Factor  :  6.711

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • 6th International Conference on Human and Soci

    Venue:FCT Education Resource Center, Abuja- Nigeria                                        September 22-24, 2019

  • .

    6th INTERNATIONAL CONFERENCE ON EDUCATIONAL TECHNOLOGY AND CURRICULUM STUDIES(ICETC2019) 

     

    Venue: FCT Education Resource Center, Abuja-Nigeria

    September 22-24, 2019

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR May 2024 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased to 6.711 for Year 2024.

  • WJAHR: MAY ISSUE PUBLISHED

    MAY 2024 Issue has been successfully launched on 1 MAY 2024.

Best Paper Awards

World Journal of Advance Healthcare Research (WJAHR)Honored the authors with best paper award, monthly based on the innovation of research work. Best paper will be selected by our expert panel.

Best Article of current issue

Download Article : Click here

Indexing

  Indexing

  • Google Scholar
  • Index Copernicus
  • SOCOLAR, China
  • Research Bible, Fuchu, Tokyo. JAPAN
  • Cosmos Impact Factor
  • Scientific Indexing Services (SIS)
  • UDLedge Science Citation Index
  • International Impact Factor Services
  • International Society for Research Activity (ISRA) Journal Impact Factor (JIF)
  • IFSIJ Measure of Journal Quality
  • Scientific Journal Impact Factor (SJIF)
  • International Scientific Indexing, UAE (ISI) (Under Process)
  • International Impact Factor Services (IIFS)
  • Web of Science Group (Under Process)
  • Directory of Research Journals Indexing
  • Scholar Article Journal Index (SAJI)
  • International Scientific Indexing ( ISI )
  • Academia
  • Scope Database

Abstract

COMPARISON OF OUTCOMES BETWEEN 25MCG AND 50MCG DOSING REGIMENS OF VAGINAL MISOPROSTOL FOR LABOUR INDUCTION AT TERM.

Walaa Younes Jamoua*, Maison Dayoub and Ahmad Yousef

ABSTRACT

Background: Misoprostol is a prostaglandin E-1 analogue which induces uterine contractions and cervical dilatation to reduce primary cesarean section and improve final outcome regarding subsequent pregnancies. Aim: The purpose of this study was to evaluate the effectiveness of different doses of vaginal misoprostol for medical induction of labor and compare the side effects of the two doses. Materials and Methods: A Prospective study conducted for the period one year (2022- 2023) at Tishreen University Hospital in Lattakia-Syria. The study included 100 pregnant women at full term who had indication for induction of labor, and were divided into group A (50): women were administrated 25 µg of vaginal misoprostol, and group B(50): women were administrated 50 µg of vaginal misoprostol. Results: The mean age was 26.33±1.88 years, without significant differences between the two groups regarding age, gestational age, obstetric history, body mass index, status of cervix, etiology of labor induction, and mean induction -abortion interval. The rate of induction success was 88% in group A versus 94% in group B without significant difference, p:0.6. Vaginal delivery was observed more frequently in group B(78% versus 74%, P:0.2) without presence of significant difference between two groups regarding complications (p> 0.05). The rate of responsive to induction was higher in pregnant women in the following cases: advanced age, low body mass index, gestational age group (40-42 weeks), Bishop score (5-6) and multiparous but without significant difference(p>0.05). Conclusion: Our study findings suggest that misoprostol in low dose represents a safe and effective alternative to high doses for induction of labor at full term.

[Full Text Article] [Download Certificate]